SAN DIEGO (MedPage Today) -- The investigational antifibrotic agent pirfenidone slows progression of idiopathic pulmonary fibrosis, a large, randomized trial showed.
ATS: Antifibrotic Slows IPF Progress (CME/CE)Courtesy MedPage Today Allergy & Immunology Mon, 05/18/2009 - 10:20
SAN DIEGO (MedPage Today) -- The investigational antifibrotic agent pirfenidone slows progression of idiopathic pulmonary fibrosis, a large, randomized trial showed. More related itemsFaster, Simpler Seizure Rx More Effective, Too...
Amiodarone After Lung Surgery Cuts Afib (CME/CE)
Reflux Drugs No Help for Children With Asthma...
|
Popular by tags WeekMonth |
Post new comment